Answers are grounded in this paper and cite their sources.
Retrospective analysis reports primary patency of 69.2% at 36 months in patients with calcified femoropopliteal lesions, suggesting effective long-term outcomes with this approach.
Background Calcified femoropopliteal lesions remain a major challenge in peripheral endovascular interventions. Vessel preparation with atherectomy before drug‐coated balloon (DCB) angioplasty has been proposed to improve long‐term outcomes, but evidence remains limited. Aims To evaluate the 3‐year clinical outcomes of Jetstream atherectomy combined with Ranger DCB angioplasty in patients with calcified femoropoplite. Methods This retrospective, single‐center study included 50 patients (74% male, mean age 72.7 ± 9.8 years) treated between 2016 and 2020 for 63 femoropopliteal lesions. Lesions were classified as severely calcified in 56% of cases and TASC C‐D in 54%. Jetstream atherectomy was performed before Ranger DCB angioplasty. The primary endpoint was primary patency at 36 months, defined as freedom from restenosis or target lesion revascularization (TLR). Secondary endpoints included freedom from TLR and target vessel revascularization (TVR), Rutherford category and ankle‐brachial index (ABI) improvement, limb salvage, and all‐cause mortality. Results TThe mean lesion length was 122.8 ± 78.9 mm. Bailout stenting was required in 6.3% of cases. Primary patency was 91.7% at 12 months and 69.2% at 36 months. Freedom from TLR was 98.4% at 12 months and 92.0% at 36 months. TVR freedom at 36 months was 82.0%. Rutherford improvement was observed in 92.0% of patients at 1 month and sustained in 84.0% at 36 months. ABI ≥ 0.9 was achieved in 69.4% at 1 month and 68.6% at 36 months. No major amputations or cardiovascular deaths occurred during follow‐up. Conclusion Jetstream atherectomy combined with Ranger DCB angioplasty provided sustained long‐term patency, low reintervention rates, and durable clinical benefit in patients with calcified femoropopliteal lesions. Further prospective trials are needed to validate these findings.
No takes yet. Share an insight, caveat, or question.
Brunet et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: